The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument.
Abstract
PURPOSE: This is the first published report on the validation of the Functional Assessment of Cancer Therapy-Breast (FACT-B), a 44-item self-report instrument designed to measure multidimensional quality of life (QL) in patients with breast cancer. The FACT-B consists of the FACT-General (FACT-G) plus the Breast Cancer Subscale (BCS), which complements the general scale with items specific to QL in breast cancer. The FACT-B was developed with an emphasis on patients' values and brevity and is available in nine languages. METHODS AND RESULTS: Two validation samples were used for this report. The first (n = 47) was tested twice over a 2-month period to assess sensitivity to change. Significant sensitivity to change in performance status rating (PSR) was demonstrated for the FACT-B total score, the Physical Well-Being (PWB) subscale, the Functional Well-Being (FWB) subscale, and the BCS. Sensitivity to change in QL as measured by the Functional Living Index-Cancer (FLIC) was documented in the FACT-B total score, PWB, FWB, and Emotional Well-Being (EWB). Additional validity and reliability data were obtained from a larger sample (n = 295). The alpha coefficient (internal consistency) for the FACT-B total score was high (alpha = .90), with subscale alpha coefficients ranging from .63 to .86. Evidence supported test-retest reliability, as well as convergent, divergent, and known groups validity. CONCLUSION: The FACT-B is appropriate for use in oncology clinical trials, as well as in clinical practice. It demonstrates ease of administration, brevity, reliability, validity, and sensitivity to change.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The observed mean improvements presented within this evaluation exceeded this for both groups.”
In the citing paper
“All measures were validated, brief, and non-redundant, supporting parsimony while enabling comprehensive evaluation of intervention impact.”
Citations
Cites
Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., Filiberti, A., Flechtner, H., Fleishman, S. B., Haes, J. C. J. M. D., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.5.365 · Cited by 16,005
Impact of Event Scale: A Measure of Subjective Stress
Horowitz, M., Wilner, N., & Alvarez, W. (1979) · Psychosomatic Medicine · doi:10.1097/00006842-197905000-00004 · Cited by 7,813
MCHORNEY, C. A., JOHNE, W., & ANASTASIAE, R. (1993) · Medical Care · doi:10.1097/00005650-199303000-00006 · Cited by 6,681
The functional assessment of cancer therapy scale: development and validation of the general measure
Cella, D. F., Tulsky, D. S., Gray, G., Sarafian, B., Linn, E., Bonomi, A., Silberman, M., Yellen, S. B., Winicour, P., & Brannon, J. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.3.570 · Cited by 6,020
Self-citationShort, homogeneous versions of the Marlow-Crowne Social Desirability Scale
Strahan, R. F., & Gerbasi, K. C. (1972) · Journal of Clinical Psychology · doi:10.1002/1097-4679(197204)28:2 · Cited by 1,657
Sprangers, M. A., Groenvold, M., Arraras, J. I., Franklin, J., te Velde, A., Muller, M., Franzini, L., Williams, A., de Haes, H. C., Hopwood, P., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.10.2756 · Cited by 1,220
Estimates of the worldwide frequency of sixteen major cancers in 1980
Parkin, D. M., Läärä, E., & Muir, C. S. (1988) · International Journal of Cancer · doi:10.1002/ijc.2910410205 · Cited by 1,057
Schipper, H., Clinch, J., McMurray, A., & Levitt, M. (1984) · Journal of Clinical Oncology · doi:10.1200/jco.1984.2.5.472 · Cited by 1,052
Zubrod, C. G., Schneiderman, M. A., Frei, E., Brindley, C. O., Gold, G. L., Shnider, B. I., Oviedo, R., Gorman, J. G., Jones, R., Jonsson, U., et al. (1960) · Journal of Chronic Diseases · doi:10.1016/0021-9681(60)90137-5 · Cited by 1,034
Who should measure quality of life, the doctor or the patient?
Slevin, M., Plant, H., Lynch, D., Drinkwater, J., & Gregory, W. M. (1988) · British Journal of Cancer · doi:10.1038/bjc.1988.20 · Cited by 903
Flagged first, then by citations
Cited by
Sorted by citations
Items 701–800 of 1,004
Oliveira, I. S., Costa, L. D. C. M., Fagundes, F. R. C., & Cabral, C. M. N. (2014) · Quality of Life Research · doi:10.1007/s11136-014-0840-3 · Cited by 33
“questionnaires can be found in the literature, such as the European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire (EORTC QLQ-BR23) [8], the Functional Assessment of Cancer Therapy-Breast (FACT-B), and the Functional Assessment of Cancer Therapy-Breast plus Arm M…”
MethodThe relationship between body image, age, and distress in women facing breast cancer surgery
Miller, S. J., Schnur, J. B., Weinberger-Litman, S. L., & Montgomery, G. H. (2013) · Palliative & Supportive Care · doi:10.1017/s1478951513000321 · Cited by 35
“The items read: “I feel sexually attractive,” and “I am able to feel like a woman” (Brady et al., 1997).”
BackgroundBelkora, J. K., Katapodi, M. C., Moore, D. H., Franklin, L., Hopper, K., & Esserman, L. J. (2006) · Patient Education and Counseling · doi:10.1016/j.pec.2006.03.017 · Cited by 33
Quality of Life in Long-Term Survivors of Metastatic Breast Cancer
Meisel, J. L., Domchek, S. M., Vonderheide, R. H., Giobbie‐Hurder, A., Lin, N., Winer, E. P., & Partridge, A. H. (2012) · Clinical Breast Cancer · doi:10.1016/j.clbc.2012.01.010 · Cited by 34
Sehlen, S., Hollenhorst, H., Lenk, M., Schymura, B., Herschbach, P., Aydemir, U., & Dühmke, E. (2002) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(01)02600-1 · Cited by 33
Amichetti, M., Caffo, O., Arcicasa, M., Roncadin, M., Lora, O., Rigon, A., Zini, G., Armaroli, L., Coghetto, F., Zorat, P., et al. (1999) · Breast Cancer Research and Treatment · doi:10.1023/a:1006125602353 · Cited by 33
“However, although a number of articles have been published and many scales specific for this disease have been developed [20, 21], there is currently no gold standard for measuring the QL in BC patients [22].”
BackgroundWu, Y., Amonkar, M. M., Sherrill, B. H., O’Shaughnessy, J., Ellis, C. E., Baselga, J. M., Blackwell, K., & Burstein, H. J. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr014 · Cited by 32
Phase 2 pilot study of Pathfinders: a psychosocial intervention for cancer patients
Abernethy, A. P., Herndon, J. E., Sykes, A. D., Staley, T., Wheeler, J. L., Rowe, K., Smith, S. K., & Lyerly, H. K. (2010) · Supportive Care in Cancer · doi:10.1007/s00520-010-0823-z · Cited by 32
“Electronic instruments included: (1) Functional Assessment of Cancer Therapy — Breast Cancer Scale (FACT-B) [8, 9] Services, Inc.) [12], an 86-item review of systems, generating seven subscales including a global QOL score.”
Winters, Z., Afzal, M., Balta, V., Freeman, J., Llewellyn-Bennett, R., Rayter, Z., Cook, J., Greenwood, R., King, M. T., Hallam, S., et al. (2016) · British journal of surgery · doi:10.1002/bjs.10102 · Cited by 32
Swanick, C. W., Lei, X. J., Shaitelman, S. F., Schlembach, P. J., Bloom, E. S., Fingeret, M. C., Strom, E. A., Tereffe, W., Woodward, W. A., Stauder, M. C., et al. (2016) · Cancer · doi:10.1002/cncr.30121 · Cited by 32
“White non-Hispanic 116 (78) 99 (72) Hispanic 16 (11) 20 (15) Black non-Hispanic 15 (10) 17 (12) Asian non-Hispanic 2 (1) 2 (1) BMI, kg/m(2) .”
An, K., Kang, D., Morielli, A. R., Friedenreich, C. M., Reid, R. D., McKenzie, D. C., Gelmon, K. A., Mackey, J. R., & Courneya, K. S. (2020) · International Journal of Behavioral Nutrition and Physical Activity · doi:10.1186/s12966-020-00924-9 · Cited by 32
Zhou, K., Wang, W., Li, M., An, J., Huo, L., He, X., Li, J., & Li, X. (2020) · Health and Quality of Life Outcomes · doi:10.1186/s12955-020-01400-5 · Cited by 32
Brunelle, C. L., Roberts, S. A., Horick, N., Gillespie, T. C., Jacobs, J. M., Daniell, K. M., Naoum, G. E., & Taghian, A. G. (2020) · Physical Therapy · doi:10.1093/ptj/pzaa162 · Cited by 32
A randomized intervention involving family to improve communication in breast cancer care
Wolff, J. L., Aufill, J., Echavarria, D. M., Blackford, A. L., Connolly, R. M., Fetting, J. H., Jelovac, D., Papathakis, K., Riley, C. D., Stearns, V., et al. (2021) · npj Breast Cancer · doi:10.1038/s41523-021-00217-9 · Cited by 31
Bu, X., Jin, C., Fan, R., Cheng, A. S. K., Ng, P. H. F., Xia, Y., & Liu, X. (2022) · BMC Cancer · doi:10.1186/s12885-022-09224-w · Cited by 32
Jeffe, D. B., Pérez, M., Cole, E. F., Liu, Y., & Schootman, M. (2015) · Annals of Surgical Oncology · doi:10.1245/s10434-015-4926-0 · Cited by 36
“At each interview, we measured QOL using the Functional Assessment of Cancer Therapy-Breast (FACT-B) Version 4.(38) FACT-B total scores range from 0 to 144, with higher scores reflecting better QOL.”
MethodFenlon, D., Powers, C., Simmonds, P., CLOUGH, J. B., & Addington-Hall, J. M. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-467 · Cited by 32
“To assess quality-of-life and functional status the FACT-G/FACTB/FACT-ES [34,35] and the SF-36 [36] were used.”
MethodDyspnea and Panic Among Patients With Newly Diagnosed Non-Small Cell Lung Cancer
Shin, J. A., Kosiba, J. D., Traeger, L., Greer, J., Temel, J., & Pirl, W. (2014) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2013.10.021 · Cited by 29
Owen, J. E., Bantum, E. O., Criswell, K. R., Bazzo, J., Gorlick, A., & Stanton, A. L. (2013) · Journal of Behavioral Medicine · doi:10.1007/s10865-013-9509-6 · Cited by 32
“This instrument has adequate internal consistency (overall a = .90, subscale a’s = .63–.86) and good concurrent validity with ECOG performance status (Brady et al., 1997).”
BackgroundA Phase I Trial of Intralesional rV-Tricom Vaccine in the Treatment of Malignant Melanoma
Kaufman, H. L., DeRaffele, G., DiVito, J., Hörig, H., Lee, D., Panicali, D., & Voulo, M. (2001) · Human Gene Therapy · doi:10.1089/104303401750298616 · Cited by 32
“This survey has been used previously and validated (57–58).”
The Effect of Pain on Physical Functioning After Breast Cancer Treatment
Andersen, K. G., Christensen, K. B., Kehlet, H., & Bidstrup, P. E. (2014) · Clinical Journal of Pain · doi:10.1097/ajp.0000000000000156 · Cited by 31
Wood, R. P., Mitra, D., de Courcy, J. J., & Iyer, S. S. (2017) · Clinical Therapeutics · doi:10.1016/j.clinthera.2017.07.009 · Cited by 31
Berger, A. M., Buzalko, R. J., Kupzyk, K. A., Gardner, B. J., Sass, D., & Otte, J. L. (2017) · Acta Oncologica · doi:10.1080/0284186x.2017.1374555 · Cited by 30
“This study evaluated similarities and differences in recent experiences of breast cancer patients regarding their FACT QOL: Physical well-beinga 23.34 (4.8) 22.78 (5) FACT QOL: Social/Family well-beinga 22.91 (5.3) 22.73 (5.4) FACT QOL: Emotional well-beingb 20.12 (3.7) 19.86 (3.7) FACT QOL: Functional well-beinga 21.…”
ResultInfluentialHarvie, M., Pegington, M., McMullan, D., Bundred, N. J., Livingstone, K., Campbell, A., Wolstenholme, J. L., Lovato, E., Campbell, H., Adams, J. E., et al. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0522-6 · Cited by 31
Çömez, S., & Karayurt, Ö. (2020) · European Journal of Oncology Nursing · doi:10.1016/j.ejon.2020.101758 · Cited by 31
Ramírez, A. G., Muñoz, E., Parma, D. L., Perez, A., & Santillan, A. A. (2020) · Cancer Medicine · doi:10.1002/cam4.3272 · Cited by 31
Kang, D.-H., McArdle, T., & Suh, Y. O. (2014) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2014.0216 · Cited by 31
“The patients’ QOL was measured with the Functional Assessment of Cancer Therapy Scale–B, version 4 (FACT-B).(22,23) This 37-item questionnaire specifically targets patients with breast cancer receiving cancer treatment.”
The Zero Acceptance of Pain (ZAP)™ Quality Improvement Project
Fortner, B. V., Okon, T. A., Ashley, J., Kepler, G., Chavez, J., Tauer, K. W., Clements-Thompson, M., Schwartzberg, L. S., DeMarco, G. A., & Houts, A. C. (2003) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(02)00679-6 · Cited by 31
Quality-of-Life Outcomes in Oncology
Siddiqui, F., Kachnic, L. A., & Movsas, B. (2006) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2006.01.003 · Cited by 31
Reed, R. G., Weihs, K. L., Sbarra, D. A., Breen, E. C., Irwin, M. R., & Butler, E. A. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.02.018 · Cited by 35
“Functional Assessment of Cancer Therapy: Physical Well-Being Scale (FACT-PWB) assessed sickness symptoms and their effects on physical functioning (Brady et al., 1997).”
Quality of Life in Patients With Advanced Non-Small Cell Lung Cancer
Bozcuk, H. S., Dalmis, B., Samur, M., Özdoğan, M., Artaç, M., & Savaş, B. (2006) · Cancer Nursing · doi:10.1097/00002820-200603000-00004 · Cited by 31
Emerson, M. A., Reeve, B. B., Gilkey, M. B., Elmore, S. N. C., Hayes, S. C., Bradley, C. J., & Troester, M. A. (2022) · Journal of Cancer Survivorship · doi:10.1007/s11764-022-01252-6 · Cited by 30
Coronado, P., Sánchez‐Borrego, R., Palacios, S., Ruiz, M. Á., & Rejas, J. (2014) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000321 · Cited by 30
Fagundes, C. P., Jaremka, L. M., Malarkey, W. B., & Kiecolt‐Glaser, J. K. (2014) · Psycho-Oncology · doi:10.1002/pon.3492 · Cited by 30
“The current study examined how individual differences in breast cancer survivor’s attachment style and self-regulatory capacity (as indexed by RSA) were associated with QOL among cancer survivors [29].”
Popovic, M. M., Nguyen, J., Chen, E., Giovanni, J. D., Zeng, L., & Chow, E. (2012) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/erp.11.99 · Cited by 30
Correlates of objectively measured sedentary behavior in breast cancer survivors
Phillips, S. M., Lloyd, G. R., Salerno, E. A., & McAuley, E. (2016) · Cancer Causes & Control · doi:10.1007/s10552-016-0756-z · Cited by 35
“Functional Assessment of Cancer Therapy-Breast (FACTB) [29, 30].”
Neugut, A. I., Hillyer, G. C., Kushi, L. H., Lamerato, L. E., Buono, D. L., Nathanson, D. S., Bovbjerg, D. H., Mandelblatt, J. S., Tsai, W., Jacobson, J. S., et al. (2016) · Breast Cancer Research and Treatment · doi:10.1007/s10549-016-3855-3 · Cited by 34
“The FACT-B is a multidimensional measure that consists of subscales to assess physical, social, emotional, functional well-being, and a subscale specific to quality of life among breast cancer patients.”
InfluentialEffectiveness of therapy group in women with localized breast cancer
Pérez, A. B., Peris-Juan, C., & Santaballa, A. (2019) · International Journal of Clinical and Health Psychology · doi:10.1016/j.ijchp.2019.02.001 · Cited by 31
Abernethy, A. P., Wheeler, J. L., & Zafar, S. Y. (2010) · Current Opinion in Supportive and Palliative Care · doi:10.1097/spc.0b013e32833575fd · Cited by 30
Sohl, S. J., Levine, B. J., & Avis, N. E. (2014) · Quality of Life Research · doi:10.1007/s11136-014-0749-x · Cited by 31
Gonzales, F. A., Hurtado‐de‐Mendoza, A., Santoyo‐Olsson, J., & Nápoles, A. M. (2015) · Psycho-Oncology · doi:10.1002/pon.3953 · Cited by 30
“The emotional well-being subscale of the Functional Assessment of Cancer Therapy QoL instrument was the outcome measure [28].”
MethodPerioperative rehabilitation in operation for lung cancer (PROLUCA) – rationale and design
Sommer, M. S., Trier, K., Vibe-Petersen, J., Missel, M., Christensen, M., Larsen, K. R., Langer, S. W., Hendriksen, C., Clementsen, P. F., Pedersen, J. H., et al. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-404 · Cited by 30
Lien, K. R., Zeng, L., Nguyen, J., Cramarossa, G., Culleton, S., Caissie, A. L., Lutz, S. S., & Chow, E. (2011) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/erp.11.64 · Cited by 30
Yanez, B. R., Buitrago, D., Buscemi, J., Iacobelli, F., Adler, R. F., Corden, M. E., Perez-Tamayo, A. M., Guitelman, J., & Penedo, F. J. (2017) · Contemporary Clinical Trials · doi:10.1016/j.cct.2017.11.018 · Cited by 30
“All the items in this survey were forward and backward translated to Spanish, and piloted with a sample of 24 patients during the feasibility trial of My Guide[36].”
MethodInfluentialLi, C., Lai, C., Qiu, Q., Luo, X., Hu, L., Zheng, H., Lü, Y., Liu, M., Zhang, H., Liu, X., et al. (2019) · AAPS PharmSciTech · doi:10.1208/s12249-019-1385-0 · Cited by 30
Lash, T. L., Clough‐Gorr, K. M., & Silliman, R. A. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-004-1472-z · Cited by 30
“Interviews began before two more well-known measures of breast cancer-related worries had been established [22, 23].”
BackgroundHarder, H., Langridge, C., Solis‐Trapala, I., Zammit, C., Grant, M., Rees, D., Burkinshaw, L., & Jenkins, V. A. (2015) · European Journal of Integrative Medicine · doi:10.1016/j.eujim.2015.02.002 · Cited by 29
Interdisciplinary Palliative Care Intervention in Metastatic Non–Small-Cell Lung Cancer
Koczywas, M., Cristea, M. C., Thomas, J., Mccarty, C., Borneman, T. R., Ferraro, C. D., Sun, V. C.-Y., Uman, G. C., & FERRELL, B. R. (2013) · Clinical Lung Cancer · doi:10.1016/j.cllc.2013.06.008 · Cited by 29
Vallance, J. K., Friedenreich, C. M., Lavallee, C. M., Culos-Reed, N. S., Mackey, J. R., Walley, B. A., & Courneya, K. S. (2015) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-0812 · Cited by 29
“C. Friedenreich is supported by a career award from Alberta Innovates-Health Solution and the Alberta Cancer FoundationWeekend to End Women's Cancers Breast Cancer Chair.”
MethodInfluentialSaltbæk, L., Karlsen, R. V., Bidstrup, P. E., Høeg, B. L., Zoffmann, V., Horsbøl, T. A., Holländer, N. H., Svendsen, M. N., Christensen, H. G., Dalton, S. O., et al. (2019) · Acta Oncologica · doi:10.1080/0284186x.2018.1563717 · Cited by 33
“The primary outcome is breast cancer-specific health-related quality of life as measured by the Trial Outcome Index-Physical/Functional/Breast (TOI-PFB) score of the Danish version of the Functional Assessment of Cancer Therapy-Breast (FACT-B) [23] 2 years after study entry [24].”
Methodde Maar, J. S., Suelmann, B. B. M., Braat, M. N. G. J. A., van Diest, P. J., Vaessen, H. H. B., Witkamp, A. J., Linn, S., MOONEN, C. T. W., van der Wall, E., & Deckers, R. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-040162 · Cited by 29
Okamoto, T., Shimozuma, K., Katsumata, N., Koike, M., Hisashige, A., Tanaka, K., Ohsumi, S., Saito, M., Shikama, N., Mitsumori, M., et al. (2003) · Breast Cancer · doi:10.1007/bf02966719 · Cited by 29
Walker, L. G., Eremin, J. M., Aloysius, M. M., Vassanasiri, W., Walker, M. B., El‐Sheemy, M., Cowley, G., Beer, J., Samphao, S., Wiseman, J., et al. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-179 · Cited by 29
“Before randomisation, and three weeks after completion of docetaxel, patients completed the Functional Assessment of Cancer Therapy-Breast (FACT-B) questionnaire (version 3) and the Rotterdam Symptom Checklist (RSCL) [20,21].”
InfluentialSpigel, D. R., Patel, J. D., Reynolds, C. H., Garon, E. B., Hermann, R. C., Govindan, R., Olsen, M. R., Winfree, K. B., Chen, J., Liu, J., et al. (2015) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000277 · Cited by 29
Yount, S., Cella, D. F., Banik, D., Ashraf, T., & Shevrin, D. H. (2003) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-1-69 · Cited by 29
Self-citationHealth and personal resources in older patients with cancer undergoing chemotherapy
Robb, C., Lee, A., Jacobsen, P. B., Dobbin, K. K., & Extermann, M. (2013) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2012.12.002 · Cited by 31
“The Functional Assessment of Cancer Therapy-Geriatric (FACT-G) scale, a widely used QOL scale in oncology that has been validated in older patients with cancer, was used to assess physical, social/familial, emotional, and functional well-being [50,51].”
Sherrill, B. H., Amonkar, M. M., Sherif, B. N., Maltzman, J., O’Rourke, L., & Johnston, S. R. D. (2010) · The Oncologist · doi:10.1634/theoncologist.2010-0012 · Cited by 29
Shallwani, S. M., Simmonds, M. J., Kasymjanova, G., & Spahija, J. (2016) · Lung Cancer · doi:10.1016/j.lungcan.2016.06.018 · Cited by 29
Ahmad, S., Fergus, K. D., Shatokhina, K., & Gardner, S. L. (2016) · Journal of Behavioral Medicine · doi:10.1007/s10865-016-9803-1 · Cited by 31
“The Functional Well-being subscale of the Functional Assessment of Cancer Treatment-Breast (FACT-B; Brady et al., 1997) was used to evaluate participants’ quality of life, such as their reported ability to work, complete daily activities and have a fulfilling life.”
MethodInfluentialJutagir, D. R., Blomberg, B. B., Carver, C. S., Lechner, S. C., Timpano, K. R., Bouchard, L. C., Gudenkauf, L. M., Jacobs, J. M., Diaz, A., Lutgendorf, S. K., et al. (2017) · Breast Cancer Research and Treatment · doi:10.1007/s10549-017-4316-3 · Cited by 30
Quoix, É., Breton, J.-L., Gervais, R., Wilson, J., Schramel, F. M. N. H., Cardenal, F., Ross, G. A., Preston, A. J., Lymboura, M., & Mattson, K. V. (2005) · Lung Cancer · doi:10.1016/j.lungcan.2005.02.008 · Cited by 29
Cella, D. F. (2003) · Seminars in Oncology · doi:10.1053/sonc.2003.50031 · Cited by 29
Self-citationCho, D., Chu, Q., & Lu, Q. (2018) · Supportive Care in Cancer · doi:10.1007/s00520-017-4010-3 · Cited by 28
Saltbæk, L., Bidstrup, P. E., Karlsen, R. V., Høeg, B. L., Horsbøl, T. A., Belmonte, F., Andersen, E. W., Zoffmann, V., Friberg, A. S., Svendsen, M. N., et al. (2024) · Journal of Clinical Oncology · doi:10.1200/jco.23.01447 · Cited by 28
Kim, E., Scheufele, D. A., Han, J. Y., & Shah, D. V. (2016) · Health Communication · doi:10.1080/10410236.2015.1110005 · Cited by 28
“Breast cancer concern ( M = 1.10, SD = .61, Cronbach ’ s α = .64 for pretest) gauged breast cancer patients ’ emotional, physical, and body image concerns and distress related to treatments and side effects (Brady et al., 1997).”
BackgroundMethodInfluentialPérez, M., Schootman, M., Hall, L. E., & Jeffe, D. B. (2017) · Breast Cancer Research and Treatment · doi:10.1007/s10549-017-4121-z · Cited by 28
“Improvement in neither total FACT-B nor Vitality differed significantly by RT type over 2-year follow-up.”
MethodInfluentialSong, S.-Y., Park, J.-H., Lee, J. S., Kim, J. R., Sohn, E. H., Jung, M. S., & Yoo, H. (2020) · Integrative Cancer Therapies · doi:10.1177/1534735420925519 · Cited by 28
“The recruitment period was extended in an attempt to achieve the goal of 40 patients in each group, but the enrollment was terminated because the minimum number of patients (32) had been achieved and continued recruitment was proving to be difficult.”
BackgroundVerrill, M. W., Wardley, A. M., Retzler, J., Smith, A. B., Bottomley, C. J., Dhochartaigh, S. N., Tran, I., Leslie, I., & Schmid, P. (2020) · Health and Quality of Life Outcomes · doi:10.1186/s12955-020-01603-w · Cited by 32
Tollens, F., Baltzer, P., Dietzel, M., Rübenthaler, J., Froelich, M. F., & Kaiser, C. G. (2021) · Cancers · doi:10.3390/cancers13061241 · Cited by 29
Park, H., Nam, K. E., Lim, J., Yeo, S. M., Lee, J. I., & Hwang, J. H. (2022) · Telemedicine Journal and e-Health · doi:10.1089/tmj.2022.0360 · Cited by 28
“Similar to the other outcome measures, no significant group differences were detected in the EQ-5D-5L or FACT-B scores ( p = 0.137 and 0.224, respectively).”
InfluentialTolaney, S. M., Guarneri, V., Seo, J. H., Cruz, J., Abreu, M. H., Takahashi, M., Barrios, C. H., McIntyre, K. J., Wei, R., Muñoz, M. D. M., et al. (2024) · European Journal of Cancer · doi:10.1016/j.ejca.2024.113555 · Cited by 28
Amichetti, M., & Caffo, O. (2001) · Tumori Journal · doi:10.1177/030089160108700203 · Cited by 28
“Information about therapy 3 (2) 16 (10) 44 (28) 76 (49) 17 (II)”
InfluentialPatterns, correlates, and prognostic significance of quality of life following breast cancer
DiSipio, T., Hayes, S. C., Battistutta, D., Newman, B. M., & Janda, M. (2010) · Psycho-Oncology · doi:10.1002/pon.1816 · Cited by 28
“Further, QOL was measured via the FACT, a reliable QOL instrument with good support for its validity [29], and relationships with OS were controlled for known prognostic factors.”
MethodMcLaughlin, B., Yoo, W., D’Angelo, J. D., Tsang, S. J., Shaw, B. R., Shah, D. V., Baker, T. B., & Gustafson, D. H. (2013) · Psycho-Oncology · doi:10.1002/pon.3356 · Cited by 28
“Breast cancer-related concerns [50] assessed breast cancer patients’ emotional, physical, and body image concerns related to treatments and side effects.”
BackgroundValidation of the Functional Assessment of Cancer Therapy-Breast Symptom Index (FBSI)
Yost, K. J., Yount, S., Eton, D. T., Silberman, C., Heyes, A., & Cella, D. F. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-004-5024-3 · Cited by 28
“The BCS assesses breast cancer-specific symptoms and concerns, such as arm swelling and tenderness.”
MethodInfluentialSelf-citationWeight control needs and experiences among rural breast cancer survivors
Befort, C. A., Austin, H. L., & Klemp, J. R. (2010) · Psycho-Oncology · doi:10.1002/pon.1828 · Cited by 28
“These items were chosen to assess common domains of breast cancer-specific quality of life, such as emotional, physical, and social well-being [47], while maintaining minimal participant burden.”
Belmonte, R., Garín, O., Segura, M., Pont, À., Escalada, F., & Ferrer, M. (2012) · Value in Health · doi:10.1016/j.jval.2012.06.003 · Cited by 28
Taira, N., Iwata, H., Hasegawa, Y., Sakai, T., Higaki, K., Kihara, K., Yamaguchi, T., Ohsumi, S., Shimozuma, K., & Ohashi, Y. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-2935-5 · Cited by 28
“social and family well-being (SFWB), 6 for emotional well-being (EWB), and 7 for functional well-being (FWB)] and has 9 more items on the breast cancer subscale (BCS) that are more specific to women with breast cancer [17, 18].”
BackgroundDing, Y. H., Hu, Y., & Hallberg, I. R. (2012) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-10-124 · Cited by 28
Teo, I., Fingeret, M. C., Liu, J., & Chang, D. W. (2015) · Journal of Health Psychology · doi:10.1177/1359105315589801 · Cited by 28
“Four domains of quality of life were measured using the 37-item Functional Assessment of Chronic Illness Therapy, Breast Cancer (FACT-B): physical, functional, social, and emotional well-being (Brady et al., 1997; Cella et al., 1993).”
MethodInfluentialAn innovative symptom monitoring tool for people with advanced lung cancer: a pilot demonstration.
Davis, K., Yount, S., Ciello, K. D., Whalen, M., Khan, S. A., Bass, M., Du, H., Eton, D. T., Masters, G. A., Hensing, T. A., et al. (2007) · PubMed · Cited by 28
Self-citationEnhancing Cancer Patient Well-Being With a Nonpharmacological, Heritage-Focused Intervention
Thomson, L. J. M., Ander, E. E., Menon, U., Lanceley, A., & Chatterjee, H. J. (2012) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2011.10.026 · Cited by 27
CHF-PROM: validation of a patient-reported outcome measure for patients with chronic heart failure
Tian, J., Xue, J., Hu, X., Han, Q., & Zhang, Y. (2018) · Health and Quality of Life Outcomes · doi:10.1186/s12955-018-0874-2 · Cited by 27
“Validity Content validity The patients’ opinions were typically consulted to validate the content with respect to how well the items met the empirical indexes of interest [33].”
BackgroundPromoting Emotional Well-Being in Older Breast Cancer Patients: Results From an eHealth Intervention
Villani, D., Cognetta, C., Repetto, C., Serino, S., Toniolo, D., Scanzi, F., & Riva, G. (2018) · Frontiers in Psychology · doi:10.3389/fpsyg.2018.02279 · Cited by 27
Komatsu, H., Yagasaki, K., Yamaguchi, T., Mori, A., Kawano, H., Minamoto, N., Honma, O., & Tamura, K. (2020) · European Journal of Oncology Nursing · doi:10.1016/j.ejon.2020.101780 · Cited by 27
Høeg, B. L., Frederiksen, M. H., Andersen, E. W., Saltbæk, L., Friberg, A. S., Karlsen, R. V., Johansen, C., Dalton, S. O., Horsbøl, T. A., & Bidstrup, P. E. (2020) · Journal of Cancer Survivorship · doi:10.1007/s11764-020-00964-x · Cited by 27
Díaz-Balboa, E., Salvado, V. G., Rodríguez‐Romero, B., Martínez‐Monzonís, A., Pedreira-Pérez, M., Ozores, P. P., López‐López, R., Peña, C., & González‐Juanatey, J. R. (2021) · BMC Cardiovascular Disorders · doi:10.1186/s12872-021-01970-2 · Cited by 26
Hurtado‐de‐Mendoza, A., Gonzales, F. A., Song, M., Holmes, E. J., Graves, K. D., Retnam, R. P., Gómez‐Trillos, S., Lopez, K., Edmonds, M. C., & Sheppard, V. B. (2021) · Journal of Cancer Survivorship · doi:10.1007/s11764-021-01119-2 · Cited by 27
Harvie, M., Pegington, M., Howell, S. J., Bundred, N. J., Foden, P., Adams, J. E., Graves, L., Greystoke, A., Mattson, M. P., Cutler, R. G., et al. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01650-0 · Cited by 29
“TOI-BC= PWB+ FWB+ BCS; TOI endocrine symptoms (TOI-ES) PWB+ FWB+ ESS; TOI fatigue (TOI-F)= PWB+ FWB+ FSS [22].”
InfluentialRandomized trial of therapeutic group by teleconference
Heiney, S. P., Underwood, S. M., Tavakoli, A. S., Adams, S. A., Wells, L. M., & Bryant, L. H. (2011) · Cancer · doi:10.1002/cncr.26676 · Cited by 27
“Our original power analysis was conducted using published data from the FACT total score.(60) This analysis determined that a sample of 216 was estimated to yield 90% power for outcome measures at each time point using a 1-sided hypothesis test with .”
MethodFitzHenry, F., Wells, N. L., Slater, V. E., Dietrich, M. S., Wisawatapnimit, P., & Chakravarthy, A. B. (2013) · Integrative Cancer Therapies · doi:10.1177/1534735413503545 · Cited by 29
“Sensitivity to change and validity of the breast subscale also have been reported.(24) Cronbach’s α for the observed FACT-G total scores in this study were .”
MethodCognitive strategies and quality of life of patients with high-grade glioma
Lucchiari, C., Botturi, A., Silvani, A., Lamperti, E., Gaviani, P., Innocenti, A., Finocchiaro, C. Y., Masiero, M. A., & Pravettoni, G. (2015) · Supportive Care in Cancer · doi:10.1007/s00520-015-2691-z · Cited by 30
A Psychometric Analysis of Quality of Life Tools in Lung Cancer Patients Who Smoke
Browning, K. K., Ferketich, A., Otterson, G., Reynolds, N., & Wewers, M. E. (2009) · Lung Cancer · doi:10.1016/j.lungcan.2008.12.018 · Cited by 22
Age-Related Differences in Exercise and Quality of Life among Breast Cancer Survivors
Harrison, S., Hayes, S. C., & Newman, B. M. (2009) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3181b0f2cb · Cited by 27
Koinberg, I., Langius‐Eklöf, A., Holmberg, L., & Fridlund, B. (2006) · European Journal of Oncology Nursing · doi:10.1016/j.ejon.2005.11.005 · Cited by 27
Fergus, K. D., Ahmad, S., McLeod, D. L., Stephen, J. E., Gardner, S. L., Pereira, A., Warner, E., & Carter, W. (2015) · Trials · doi:10.1186/s13063-014-0534-8 · Cited by 28
Ottenbacher, A. J., Sloane, R. J., Snyder, D. C., Kraus, W. E., Sprod, L. K., & Demark‐Wahnefried, W. (2012) · Integrative Cancer Therapies · doi:10.1177/1534735412449734 · Cited by 28
“Both the FACT-B and FACT-P are reliable and valid instruments for assessment of cancer-specific concerns and quality of life among breast and prostate cancer survivors, respectively.(7,8)”
BackgroundMethodHooker, G. W., King, L., Vanhusen, L., Graves, K. D., Peshkin, B. N., Isaacs, C. J., Taylor, K. L., Poggi, E. A., & Schwartz, M. D. (2014) · Hereditary Cancer in Clinical Practice · doi:10.1186/1897-4287-12-9 · Cited by 27
“89) [32].”
Elumelu, T. N., Asuzu, C. C., & Akin‐Odanye, E. O. (2014) · BMJ Supportive & Palliative Care · doi:10.1136/bmjspcare-2012-000409 · Cited by 27
Liu, P., You, J., Loo, W. T. Y., Sun, Y., He, Y., Sit, H., Jia, L., Wong, M.-K., Xia, Z., Zheng, X., et al. (2017) · Quality of Life Research · doi:10.1007/s11136-017-1576-7 · Cited by 26
Retracted
Metadata
- Authors
- Brady, M. J., Cella, D. F., Mo, F., Bonomi, A. E., Tulsky, D. S., Lloyd, S. R., Deasy, S., Cobleigh, M., & Shiomoto, G.
- Affiliations
- Rush University Medical Center (US)
- Rush University (US)
- Venue
- Journal of Clinical Oncology
- Published
- 1997-03
- Volume
- 15
- Issue
- 3
- Pages
- 974-986
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W1857624176
- Cited by
- 1,752
- References
- 39
- Citations by year
- 2026: 47 · 2025: 76 · 2024: 77 · 2023: 71 · 2022: 97 · 2021: 88 · 2020: 78 · 2019: 87 · 2018: 83 · 2017: 85 · 2016: 83 · 2015: 73 · 2014: 83 · 2013: 70 · 2012: 86
- FWCI
- 5.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Clinical Oncology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (1r29ca051926-01a1)
- National Cancer Institute (R29CA51926)
- Topics
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Health Sciences › Nursing › Research and Theory › Health Education and Validation
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Keywords
- FACT-B, breast cancer, quality of life, FACT-G, instrument validation, sensitivity to change, test-retest reliability, internal consistency, known-groups validity, convergent validity, discriminant validity, physical well-being, functional well-being, emotional well-being, Functional Living Index-Cancer, self-report questionnaire
- MeSH terms
- Adult, Aged, Aged, 80 and over, Breast Neoplasms, Female, Humans, Middle Aged, Quality of Life, Self Concept, Sensitivity and Specificity, Severity of Illness Index, Translations, Reproducibility of Results
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review